ST. LOUIS (AP) -- Government agencies have seized more than $24 million worth of unapproved new drugs from St. Louis-based KV Pharmaceutical Co.
Federal officials said Tuesday the drugs were made after the Food and Drug Administration told the company to stop production.
Authorities said KV Pharmaceutical had not complied with a directive that certain time-released drugs must be approved by the FDA to ensure the safe and effective release of active ingredients.
Inspectors also found that the company was manufacturing and distributing other unapproved new drugs used to treat coughs, colds and gastrointestinal conditions.
In a written statement, KV Pharmaceutical said it was set to dispose of its inventory of certain drug products signaling the conclusion of discussions with the FDA.